Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vadadustat Phase 2 in Japanese NDD-CKD Anemia
NCT03054337Phase 2Completed
- Sponsor
- Akebia Therapeutics
- Start
- Oct 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vadadustat in anemia of chronic kidney disease (CKD-A), sponsored by Akebia Therapeutics. Started Oct 2016; status: completed.
02
Drugs
vadadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT03054337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03054337.